Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Foot swelling" patented technology

The most common foot and ankle injuries that cause swelling include ankle sprains, torn tendons, and fractures. Chronic stress or overuse can lead to tendonitis, bursitis, and ligament or muscle strains, all potential causes of swelling.

Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof

The invention discloses a pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and a preparation method thereof. The pharmaceutical composition comprises scammoniae radix, Wahlenbergia marginata, wild goose fat, euonymus bungeanus, radix artocarpi styracifolii, Pternopetalum nudicaule, madder root, corydalis amabilis, acanthopanax, Galium elegans, wild chervil, white plum flower, herba asari, gleditsia japonica, bayberry root, aquilaria wood, Limonium sinense, sweet broomwort herb, barley, areca peel, Parthenocissus tricuspidata and phoenix tree leaf as main materials and evening primrose oil, gentrin knotweed extract and phosphatidylcholine bilayer as accessory materials. The pharmaceutical composition is used for treating qi deficiency and blood stasis-type apoplexy symptoms such as hemiplegia, sluggish speech or mutistic, palpitation, loose stool and hand and foot swelling, contains the main medicinal materials with effects of tonifying qi, promoting blood circulation, dredging collaterals, removing stasis, reducing phlegm and inducing resuscitation, tonifying qi and invigorating spleen, and disinhibiting dampness and auxiliary medicinal materials with effects of adjusting blood pressure and blood fat, has good prevention and control effects on hypertension, cerebral apoplexy and heart disease, is safe, has no toxic or side effect and provides a novel drug choice for patients suffering from qi deficiency and blood stasis-type apoplexy.
Owner:刘庆春

Artemisia japonica homogeneous polysaccharides as well as preparation method and application thereof

The invention discloses Artemisia japonica homogeneous polysaccharides as well as a preparation method and an application thereof. The Artemisia japonica homogeneous polysaccharides are obtained through column chromatographic separation and purification after water extraction and alcohol precipitation of all grass of Artemisia japonica, are inulin type fructan which is connected by fructose through 1,2 and contains a glucosyl group at the terminal, contain no uronic acid and have the weight-average molecular weight ranging from 1 kDa to 20 kDa. Experiment results indicate that the Artemisia japonica homogeneous polysaccharides can obviously reduce the foot swelling degree of mice suffering from collagen-induced arthritis and levels of inflammatory factors IL-6 and IL-17A in serum of the mice, are expected to be used as a major or unique active ingredient for preparation of health-care food or pharmaceutic preparations for preventing or / and treating rheumatoid arthritis, and have the important significance in research and development of Artemisia japonica pharmaceutic preparations having the clinical application value; besides, the preparation method is simple, high-purity Artemisia japonica homogeneous polysaccharides can be obtained, and the method is suitable for large-scale production and good in practicability.
Owner:SHANGHAI UNIV OF T C M

Medicine for treating damp-heat foot swelling of duckling and preparation method thereof

The invention provides a medicine for treating damp-heat foot swelling of a duckling. Every 100g of the medicine is prepared from 3g of rhizoma atractylodis, 2g of talc, 3g of cortex phellodendri, 1g of rhizoma acori graminei, 1g of radix achyranthis bidentatae, 15g of Chinese granesbill, 15g of herba aleuritopteris subvillosa, 6g of herba juncus bufonius, 30g of root or stem of delavay rockvine, 15g of Omei Mountain bambusa, 30g of herba monochoria vaginalis, 3g of root of ampelopsis japonica, 5g of radix scutellariae and 12g of flos chrysanthemi indici. When the rhizoma atractylodis, the talc, the cortex phellodendri and the rhizoma acori graminei are prepared, impurities are picked out, and the raw barks are scraped; when being used, the rhizoma atractylodis, the talc, the cortex phellodendri and the rhizoma acori graminei are smashed, or the raw barks are scraped, and then the rhizoma atractylodis, the talc, the cortex phellodendri and the rhizoma acori graminei are soaked in warm boiled water for a while, then sliced and dried in the air. The medicine can radically treat the symptom of damp-heat foot swelling of the duckling without causing side effects; through cooperation of the rhizoma atractylodis, the cortex phellodendri and the rhizoma acori graminei, blood circulation can be promoted, the metabolism is accelerated, the dead cells on the surface are removed, and the heat is cleared, the dampness is dried, the wind is dispelled and the toxin is removed; additionally, since the properties of clearing heat and removing toxicity of the herba monochoriae vaginalis, the root of ampelopsis japonica, the radix scutellariae and the flos chrysanthemi indici, the symptom of damp-heat foot swelling of the duckling is effectively treated.
Owner:陈键

Honeysuckle leaf anti-inflammatory active component as well as preparation method and application thereof

The invention relates to a preparation method of a honeysuckle leaf anti-inflammatory active component. The preparation method comprises the following steps: 1) performing petroleum ether degreasing treatment on the crushed dry honeysuckle leaves and performing reflux extraction by using methanol to obtain a viscous crude extract; 2) dissolving the viscous crude extract by using secondary water toobtain suspension, extracting by using normal butanol and performing reduced-pressure concentration to obtain a normal butanol phase; and 3) performing column chromatography isolation on the normal butanol phase, eluting by using a methanol aqueous solution of 10 percent, 20 percent, 30 percent, 40 percent, 50 percent, 60 percent and 70 percent separately, and eluting the obtained fraction by selecting a methanol aqueous solution of 50 percent. Through research on the inhibition effect of 5-LOX, research on the anti-inflammatory effect of a mouse macrophage system RAW264.7 and research on theanti-inflammatory effect of rat foot swelling, the invention discovers that the honeysuckle leaf anti-inflammatory active component (M1) has excellent anti-inflammatory activity and can provide theoretical basis for the research and development of the anti-inflammatory medicine.
Owner:HENAN UNIVERSITY

A pharmaceutical composition for treating stroke due to qi deficiency and blood stasis and its preparation method

The invention discloses a pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and a preparation method thereof. The pharmaceutical composition comprises scammoniae radix, Wahlenbergia marginata, wild goose fat, euonymus bungeanus, radix artocarpi styracifolii, Pternopetalum nudicaule, madder root, corydalis amabilis, acanthopanax, Galium elegans, wild chervil, white plum flower, herba asari, gleditsia japonica, bayberry root, aquilaria wood, Limonium sinense, sweet broomwort herb, barley, areca peel, Parthenocissus tricuspidata and phoenix tree leaf as main materials and evening primrose oil, gentrin knotweed extract and phosphatidylcholine bilayer as accessory materials. The pharmaceutical composition is used for treating qi deficiency and blood stasis-type apoplexy symptoms such as hemiplegia, sluggish speech or mutistic, palpitation, loose stool and hand and foot swelling, contains the main medicinal materials with effects of tonifying qi, promoting blood circulation, dredging collaterals, removing stasis, reducing phlegm and inducing resuscitation, tonifying qi and invigorating spleen, and disinhibiting dampness and auxiliary medicinal materials with effects of adjusting blood pressure and blood fat, has good prevention and control effects on hypertension, cerebral apoplexy and heart disease, is safe, has no toxic or side effect and provides a novel drug choice for patients suffering from qi deficiency and blood stasis-type apoplexy.
Owner:刘庆春

Multifunctional outdoor breathable sports shoe

The invention discloses a multifunctional outdoor breathable sports shoe in the technical field of boots. The multifunctional outdoor breathable sports shoe comprises a sole, an inner vamp and an outer vamp, the sole is fixedly connected to the bottom of the inner vamp, a plurality of breathable holes are formed in the two sides and the top of the inner vamp, toe openings are formed in the positions, close to toes, of the inner vamp, and the outer vamp wraps the outer side of the inner vamp; the bottom of the outer side of the outer vamp is wrapped by first wrapping cloth, the bottom of the first wrapping cloth is fixedly connected with a rubber strip, the inner side of the rubber strip is fixedly connected with a first son hook-and-loop fastener, the first son hook-and-loop fastener is provided with a first mother hook-and-loop fastener in an adhesive mode, the first mother hook-and-loop fastener is fixedly connected to the outer side of the sole and a zipper strip is arranged on the outer vamp close to the heel. The problems that feet often feel cold when wearing existing sports shoes with a good ventilation effect in winter, sports shoes with a poor ventilation effect fail to volatilize foot sweat of a user in summer, foot odor and beriberi are caused if the foot sweat is light, foot swelling is possibly caused if the foot sweat is serious, and the use feeling of a user is severely reduced are solved.
Owner:浙江卓诗尼鞋业有限公司

Qingcijian esterol sublingual tablet and preparation method thereof

ActiveCN108186624BExcellent antipyretic, analgesic and anti-inflammatory effectsRelieve pressureAntipyreticAnalgesicsPEG 400Cyclodextrin
The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to a prinsepiol sublingual tablet and a preparation method thereof. The prinsepiol sublingual tablet comprises 1-10 parts of prinsepiol cyclodextrin inclusion, 15-20 parts of filling agent, 1-5 parts of polyethylene glycol 400, 1-6 parts of disintegrant, 1-5 parts of corrigent and 0.5-5 parts of lubricant. Application of prinsepiol in preparing medicine compositions with antipyretic, analgesic and anti-inflammatory functions is provided for the first time. It is proved through a mouse hot plate method and rat carrageenin caused foot swelling experiments that prinsepiol has excellent antipyretic and anti-inflammatory functions. The novel preparation of the prinsepiol sublingual tablet is provided for the first time, the formula is reasonable, the dissolution rate, the disintegration degree and stability tests meet the requirements, and the excellent antipyretic and anti-inflammatory effects are obtained; the prinsepiol sublingual tablet is very convenient to use, is taken by a patient sublingually, is high in compliance and can reduce the pressure of conventional tablet taking, andthe sublingual tablet makes people have an psychological effect of enhancing the antipyretic and anti-inflammatory functions.
Owner:成植温
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products